Group One Trading’s Milestone Pharmaceuticals MIST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.37K Buy
6,200
+1,000
+19% +$1.11K ﹤0.01% 6637
2026
Q2
$6.97K Sell
5,200
-253,400
-98% -$405K ﹤0.01% 6589
2026
Q1
$308K Sell
258,600
-115,900
-31% -$203K ﹤0.01% 3771
2025
Q4
$756K Buy
374,500
+359,500
+2,397% +$774K ﹤0.01% 3143
2025
Q3
$30K Buy
15,000
+14,500
+2,900% +$25.5K ﹤0.01% 6369
2025
Q2
$970 Sell
500
-9,800
-95% -$13.1K ﹤0.01% 7572
2025
Q1
$8.24K Sell
10,300
-58,800
-85% -$117K ﹤0.01% 6385
2024
Q4
$163K Buy
+69,100
New +$119K ﹤0.01% 4099
2024
Q3
– Sell
-20,000
Closed -$26.6K – 7065
2024
Q2
$26.6K Hold
20,000
– – ﹤0.01% 5016
2024
Q1
$35.8K Sell
20,000
-69,900
-78% -$114K ﹤0.01% 4985
2023
Q4
$150K Hold
89,900
– – ﹤0.01% 4125
2023
Q3
$279K Buy
+89,900
New +$279K ﹤0.01% 3503
2023
Q2
– Sell
-42,800
Closed -$169K – 7992
2023
Q1
$169K Sell
42,800
-67,200
-61% -$246K ﹤0.01% 3820
2022
Q4
$436K Buy
110,000
+87,300
+385% +$460K ﹤0.01% 3170
2022
Q3
$209K Buy
+22,700
New +$172K ﹤0.01% 4106
2021
Q3
– Sell
-4,400
Closed -$24K – 8533
2021
Q2
$24K Buy
4,400
+3,100
+238% +$17.6K ﹤0.01% 7077
2021
Q1
$8K Buy
+1,300
New +$9.5K ﹤0.01% 7118

Other funds holding MIST

Group One Trading's MIST Position: Q3 2026 in Review

Group One Trading sold out of Milestone Pharmaceuticals (MIST) in Q3 2026, closing a stake of 224 shares — an estimated $249 sold.

Group One Trading first reported a position in MIST in Q3 2022 and held it in 11 quarters. The position peaked at $394K in Q4 2025. 74 funds tracked by Wall St. Rank hold MIST as of Q3 2026.

  • Group One Trading reported no remaining Milestone Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Group One Trading sold 224 Milestone Pharmaceuticals shares in Q3 2026, an estimated $249.
  • Group One Trading first reported a position in Milestone Pharmaceuticals in Q3 2022 and held it in 11 quarters.
  • Group One Trading's Milestone Pharmaceuticals position peaked at $394K in Q4 2025.
  • 74 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.